Global Innovative Platforms posts new investor deck

Global Innovative Platforms Inc. posted an updated investor presentation on its website on March 31, 2026.

Accepted by SEC EDGAR 03/31/2026 - 12:16 PM EDT

(High)

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

8-K

Rhea-AI Filing Summary

Global Innovative Platforms Inc. posted an updated investor presentation on its website on March 31, 2026. The presentation, which is furnished as Exhibit 99.1, is available under the Investor Relations section of www.vetbreath.com.

The company states that the information in this report and Exhibit 99.1 is furnished under Regulation FD, not filed, and is therefore not subject to certain Exchange Act liabilities or automatically incorporated into other securities law filings.

8-K Event Classification

2 items: 7.01, 9.01

2 items

Item 7.01 Regulation FD Disclosure Disclosure

Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, or exhibit attachments filed with this report.

Key Terms

Regulation FD Disclosure, emerging growth company, Exhibit 99.1

3 terms

Regulation FD Disclosure regulatory

"Item 7.01 Regulation FD Disclosure. On March 31, 2026, Global Innovative Platforms Inc."

Regulation FD disclosure requires public companies to share important, market-moving information with everyone at the same time instead of tipping off analysts or large investors first. Think of it as making sure all players on a field hear the same announcement simultaneously; that fairness helps investors trust that stock prices reflect the same information and reduces the risk of sudden, unfair trading advantages or regulatory penalties for selective leaks.

emerging growth company regulatory

"Emerging growth company"

An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.

Exhibit 99.1 regulatory

"A copy of the Company’s presentation is furnished as Exhibit 99.1"

Exhibit 99.1 is a label used in regulatory filings to identify a specific attached document, most often a company press release or investor presentation filed with securities regulators. For investors it matters because it marks an official, contemporaneous source of information directly tied to a filing—like the original news article pinned to a legal record—so traders and analysts treat it as an authoritative statement that can move a stock or clarify a company’s situation.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Global Innovative Platforms Inc. (GIPL) disclose in this 8-K?

Global Innovative Platforms Inc. disclosed that it posted an updated investor presentation on its website. The presentation is furnished as Exhibit 99.1 and is available in the Investor Relations section for stakeholders to review.

Where can investors find Global Innovative Platforms Inc. (GIPL)'s updated investor presentation?

The updated investor presentation is available on Global Innovative Platforms Inc.’s website, www.vetbreath.com. It can be accessed under the Investor Relations section and is also furnished as Exhibit 99.1 to this report.

How is the information in Global Innovative Platforms Inc. (GIPL)'s investor presentation treated legally?

The company states the investor presentation and related information are furnished, not filed, under the Exchange Act. This means they are not subject to Section 18 liabilities and are not incorporated into other filings unless expressly stated.

What SEC item does Global Innovative Platforms Inc. (GIPL) use for this disclosure?

The disclosure is made under Item 7.01, Regulation FD Disclosure. This item is used to provide broadly disseminated information so all investors have equal access to material company updates at the same time.

Who signed this Global Innovative Platforms Inc. (GIPL) Form 8-K?

The Form 8-K was signed on behalf of Global Innovative Platforms Inc. by Andrew Brown. He is identified in the document as the company’s Chief Executive Officer and Chief Financial Officer.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of

The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): March 31, 2026

Global Innovative Platforms Inc.

(Exact name of registrant as specified in its charter)

Delaware	000-56235	85-3816149
(State of other jurisdiction	(Commission	(IRS Employer
of incorporation)	File Number)	Identification No.)

570 Lexington Green Lane

Sanford, Florida 32881

(Address of principal executive office)

321-230-3739

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
		None

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 7.01 Regulation FD Disclosure.

On March 31, 2026, Global Innovative Platforms Inc. (the “Company”) posted an updated investor presentation on its website. A copy of the Company’s presentation is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference into this Item 7.01. The presentation will be made available on the Company’s website at www.vetbreath.com under Investor Relations. The information contained on the Company’s website shall not be deemed part of this Current Report on Form 8-K.

The information contained in this Current Report on Form 8-K, including Exhibit 99.1 furnished herewith, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (“Exchange Act”), or otherwise subject to the liabilities of that Section and shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act except to the extent expressly stated in such filing.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

Exhibit Number	Description
99.1	Investor Presentation in use beginning March 31, 2026

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Current Report to be signed on its behalf by the undersigned hereunto duly authorized.